Listed

BeOne Medicines Ltd.

ONCNasdaqCIK 1651308HealthcareFiscal year ends Dec 31

Reports and events: 376 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

BeOne Medicines Ltd., Reports and events
FiledFormWhat it isAccession number
2024-09-3006:02 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001651308-24-000123
2024-09-2606:12 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001651308-24-000118
2024-08-2907:29 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001651308-24-000110
2024-08-0706:07 ET10-QQuarterly reportPeriod 2024-06-300001651308-24-000098
2024-08-0706:04 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001651308-24-000097
2024-07-1806:40 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001651308-24-000086
2024-06-0516:35 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001651308-24-000055
2024-05-0806:09 ET10-QQuarterly reportPeriod 2024-03-310001651308-24-000051
2024-05-0806:06 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001651308-24-000049
2024-04-2616:16 ETDEF 14AProxy statementPeriod 2024-06-050001104659-24-052961
2024-04-2607:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001651308-24-000043
2024-04-2316:13 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001651308-24-000039
2024-03-2016:10 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001651308-24-000032
2024-03-1516:52 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001651308-24-000028
2024-03-0806:01 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001651308-24-000021
2024-02-2606:16 ET10-KAnnual reportPeriod 2023-12-310001651308-24-000014
2024-02-2606:02 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001651308-24-000011
2024-01-2306:03 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001651308-24-000005
2023-12-0806:01 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001651308-23-000170
2023-11-1417:18 ETSC 13D/AOwnership report, active investor, amended0001104659-23-118243
2023-11-0916:14 ET10-QQuarterly reportPeriod 2023-09-300001651308-23-000165
2023-11-0916:08 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001651308-23-000163
2023-10-2016:04 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001651308-23-000152
2023-09-2116:04 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001651308-23-000141
2023-09-1906:01 ET8-K1.02 Termination of a material agreement; 9.01 Financial statements and exhibits0001651308-23-000137
2023-08-2916:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001651308-23-000134
2023-08-0206:23 ET10-QQuarterly reportPeriod 2023-06-300001651308-23-000127
2023-08-0206:13 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001651308-23-000125
2023-07-2416:13 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001651308-23-000115
2023-07-1106:01 ET8-K1.02 Termination of a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001651308-23-000107
2023-06-1516:43 ET8-K3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits0001651308-23-000085
2023-05-2616:04 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001651308-23-000077
2023-05-0816:05 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001651308-23-000072
2023-05-0516:33 ETSC 13D/AOwnership report, active investor, amended0001104659-23-056587
2023-05-0407:17 ET10-QQuarterly reportPeriod 2023-03-310001651308-23-000068
2023-05-0407:07 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001651308-23-000066
2023-04-2716:38 ETDEF 14AProxy statement0001104659-23-051427
2023-04-2516:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001651308-23-000061
2023-04-2016:01 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001651308-23-000056
2023-03-2916:03 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001651308-23-000044
2023-02-2707:35 ET10-KAnnual reportPeriod 2022-12-310001651308-23-000036
2023-02-2707:07 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001651308-23-000031
2023-02-1416:14 ETSC 13D/AOwnership report, active investor, amended0000902664-23-001816
2023-01-3116:26 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001651308-23-000025
2023-01-2316:04 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001651308-23-000022
2023-01-0516:04 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001651308-23-000005
2022-12-1916:15 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001651308-22-000235
2022-11-2216:07 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001651308-22-000224
2022-11-0907:12 ET10-QQuarterly reportPeriod 2022-09-300001651308-22-000209
2022-11-0907:06 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001651308-22-000208

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 19:09 ET. Listed shows no prices and gives no investment advice.